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1. Introduction
  Leishmaniasis is a worldwide protozoal disease caused 
by several species of the genus Leishmania. Clinically 
leishmaniasis classified into cutaneous, mucocutaneous 
and visceral forms[1]. Cutaneous leishmaniasis (CL) is an 
important and prevalent vector born disease in Iran with 
about 20 000 new cases annually. Leishmania tropica (L. 
tropica) with about 25% and L. major with 75% frequency 
are the main etiological agents for both Anthroponotic 
and zoonotic CL that reported in more than 18 out of 31 
provinces of Iran[2].
  In the recent years there are a few reports of atypical 
clinical forms of cutaneous leishmaniasis patients[3]. 
Some studies have implicated L. tropica as another agent 
of visceral leishmaniasis in dogs and humans from the 
north-west and south of the country[4,5]. Few data are 
available, however, about host immunological response 
and parasite destruction when leishmaniasis is associated 
with immunosuppressant. At present, the majority of 
cases of HIV-leishmaniasis co-infection reported in the 
Mediterranean basin were caused by L. infantum[6]. In Iran 
there are some reports that show L. tropica is principal 
agent of VL in HIV infected patients[7].
  We report here, 4 disseminated cutaneous leishmaniasis 
patients with clinical, parasitological and molecular results. 
2. Case reports
2.1. Clinical presentation 
Patient 1
  A 41-year-old man with no particular medical history 
and systemic symptoms referred from the physician to 
the leishmaniasis lab, department of Medical Parasitology 
We report four disseminated cutaneous leishmaniasis(DCL) cases referred to leishmaniasis 
laboratory at the School of Public Health, Tehran University of Medical Sciences with multiple 
nodular, ulcerative and crusted lesions extended on the face, trunk, and extremities. None 
of the patients had any complication and historical involvement in their immunological 
system conditions that suggest as the criteria for DCL.  Direct smears of ulcers were positive 
for Leishmania parasite. The parasite was isolated from the active lesions and identified as 
Leishmania major (L. major) using PCR-RFLP assay and sequencing analysis.
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and Mycology, School of Public Health, Tehran University 
of Medical Sciences (TUMS) in November 2009. He was a 
military crew and his mission was in Dehloran from Ilam 
province located in the west of Iran near the Iraq border. 
Upon questioning, the patient described the appearance in 
the past six months (May 2009) with a number of papulo-
nodular cutaneous lesions on his hands and legs. After a 
while, various skin ulcerative lesions almost disseminated 
in his entire body. Physical examination showed that the 
patient was good in general condition, without fever but for 
the disseminated lesions and hence disability, he lived a 
very anxious and stressed life. In physical examination, most 
of cutaneous lesions were papulonodular, infiltrated without 
any typical form. The lesions were painless. The lesions 
disseminated to entire body, with the exception of the palms 
(Figure 1).
Figure 1. Patient 1 from Dehloran in the west of Iran (2009). 
                          
Patient 2 
  A 59-year-old man with no particular medical history and 
systemic symptoms referred to the laboratory in November 
2010. He was a bank staff and his mission was in Damghan, 
Semnan Province located in the center of Iran. In Recent10 
years Damghan has been reported as an important of ZCL 
focus in Iran. Upon questioning, the patient described 
the historical appearance in the past six to eight months 
(April 2009) with a number cutaneous lesions located 
on his legs. After a while, various lesions disseminated 
almost entire legs. The initial lesions became ulcerated. 
Clinical examination showed that the patient was good 
in general condition. In examination most of cutaneous 
lesions, looks like papulonodular reddish-brown and 
were infiltrated without any typical form. In this case the 
patient was systemically treated by meglumine antimoniate 
(Glucantime®) for at least 4 treatment courses. Each 
treatment courses were at least 3 weeks. Scars appeared and 
remained 6 months after the last injection (Figure 2).
Figure 2. Patient 2 from Damghan in central part of Iran (2010).
 
Patient 3 
  The third case was a 46 year-old man whose job was a 
worker. He lived in Bojnoord city, northern Khorassan 
Province-in the northeast of Iran. He was referred to a 
medical center in 2009. He was infected by Leishmania 
parasite in 1987 meanwhile, he was a volunteer fighter 
during Iran-Iraq war in Fakkeh (one of the ZCL focuses 
located in the Iran-Iraq boundary). He was also exposed to 
the side-effects of a chemical bomb during the war. After 
being infected to CL, lesions expanded all over his hand, 
probably because of the side-effects of the chemical bombs. 
The lesions also dominated palms and nails which are rare 
in such cases (Figure 3). He received 4 courses of 20 daily 
of systemically treatment with Glucantime, but no favorable 
responses were observed after 12 years because the ulcers 
were active with numerous amastigote forms of Leishmania 
sp.
Figure 3. Patient 3 from Bojnoord, in the northeast of Iran (2009).
 
Patient 4 
  A 40 year-old woman, housewife, presented with a One 
year history of skin lesions all over her body especially on 
her arms from 2003. She was infected in Esfahan, another 
important ZCL focus in the central of Iran. The patient 
described the appearance of multiple lesions on her body 
including hands, chest, and backs. The patient received 
multiple courses of systematic treatment with Glucantime® 
but not only the lesions show any healing but also they were 
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extended to new site of her bodies.
Figure 4. Patient 4 from Esfahan, centeral part of Iran( 2003).
2.2. Laboratory  presentation 
  Smears were prepared from scrapings of the popular or 
nodule lesions on different parts of bodies. Smears prepared 
from fluid materials of  some of  the  skin lesions,  stained 
with Giemsa 10%(Labtron Co, Iran)and demonstrated 
numerous Leishmania amastigote forms of Leishmania spp 
by light microscope with high magnification (1 000×) in all 
of the patients. Also in aseptically condition, skin lesion 
materials were cultured in special medium such as RPMI1640 
(Gibco) plus 10% FBS (Gibco)[8]. Promastigote forms appeared 
after about 1 to 2 weeks post inoculation but unfortunately 
in third cases, the bacterial contamination was very high 
and we missed this isolate. In cases 1, 2 and 4, DNA was 
extracted from the cultured promastigotes and in third 
case from the prepared direct stained slides[9]. To identify 
the causative agent of the diseases in above mentioned 
cases PCR-RFLP was performed. DNA extraction was 
conducted using the kit (Roche, Germany) .The ITS1 region 
amplification was performed with 35 cycles, each of 30″ at 94 
曟, 30 ″at 49 曟, and 45″ at 72 曟 in a thermo cycler (Peqlab) 
using the primers LITSR (5’-CTGGATCATTTTCCGATG-3’) 
and L5.8S (5’-TGATACCACTTATCGCACTT- 3’) . The PCR 
products were digested with HAEIII or BSUR1 (Fermentas, 
Germany) as the fast digestion restriction enzyme. Digestion 
products were separated by 3% agarose gels in TAE buffer 
and visualized after staining by ethidium bromide[8,10].
  Reference stocks: After electrophoresis the PCR pattern 
of samples was evaluated with the pattern of three Iranian 
Leishmania stock species submitted to the GenBank 
database with accession numbers, EF653267 for L. tropica,
L. major EF653269, and L. infantum EF653268.The PCR-
RFLP identified the species of all cases as L. major.
  The PCR product of two first patients were sequenced 
using the forward primer according to the manufacturer’s 
instructions (Bioneer, Korea). The two sequences documented 
as Accession numbers JN860713 and JN860714. 
3. Discussion
  Leishmaniasis includes a wide range of clinical 
signs. From cutaneous leishmaniasis to mucocutaneous, 
disseminated form to lethal visceral leishmaniasis form[11]. 
According to the taxonomical studies, different Leishmania 
complex and species are responsible for such various 
aspects of the disease[12,13]. However beside Leishmania 
various species, reservoirs, vectors, and ecological focus 
conditions play an important role. According to A.L. Bañuls, 
Leishmania parasites have clonal division. This kind of 
division and some factors such as geographical barriers 
and distance hinder genetic mixing take part in hybrid 
species production[14,15]. In recent decades there have 
been incredible advances in molecular studies either in 
diagnosis and taxonomical aspects. These advances enabled 
us to observe new complex cases. There have been some 
reported cases of CL by Leishmania infantum[16], VL by 
both L. tropica[4,7] and L. major[17]  and also some DCL cases 
caused by L. tropica[18,19]. Some of these reports pointed out 
immunology disorders in some cases. But none of the cases 
reported in this current study had any immunosuppressive 
in their medical documents and probably we should not 
underestimate the potential genomic characteristics of 
Leishmania parasites. In recent years multiplicity of 
internal and external trips and migrations from endemic 
to non-endemic areas and vice versa, and such factors 
has leaded to a change in distribution of the parasite[20,21]. 
This could lead to the production of new hybrids and 
pathogenicity signs[22,23]. It seems that the number of such 
cases is increasing. According to these kinds of evidences 
and achieved reports on different clinical signs which is 
caused by mutation in Leishamania parasite pathogenicity, 
there must be an emphasize on molecular epidemiology in 
endemic areas. We suggest DNA based molecular methods 
for Leishmania identification. The true identification of 
the causative agent of CL using the molecular methods 
is essential for treatment, control and prevention of the 
disease. 
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